Dr PP Lal Krishna, MD and CEO, Visakha Pharma City gave a special address which highlighted how Vizag offers myriad opportunities for the pharma industry to flourish and expand. He elaborated on how the port city has transformed into an industrial centre with a conducive business environment and an ideal economic climate.
He said that the pharma city is changing the face of Vizag’s industrial development and divulged some crucial details. For instance, the total investment expected in the project was Rs 25,000 crores. Likewise,it has generated employment for more than 32,000 people.
He said that many MNCs such as J&J, Merck, Amgen, Gilead, Abbvie, Sanofi, Pfizer have chosen to have facilities in Visakha Pharma City. It is also home to over 25 global generic companies including Cipla, Wockhardt, Aurobindo, Laurus, Perrigo, Mylan, etc. Speaking about its site selection and advantages, he pointed out that the Pharma City is close to the sea coast, Vizag Airport, national highways, power plants, etc, and thereby offers major benefits to the lifesciences sector. He also detailed
the physical, environmental and social infrastructure as well as other facilities available within the pharma city and in its proximity.
He also spoke about the proposed facilities in Visakha Pharma City and how it would help the sector become more compliant and competitive in the global arena. He highlighted that this project, undertaken under the PPP model, is one of the most successful pharma parks in the country. He advised the industry to make optimum use of the facilities available and propel India Pharma Inc to greater glory.
- Advertisement -